ARID5B and breast cancer: IPA showed that the pathways of mammary tumours, genitourinary tumours and extracranial solid tumours were strongly activated in G1 cells, in which AREG, ARL4C, and ARID5B showed the greatest contribution to activation (Figure 2E and Table S3).